Tech Company Financing Transactions
Galatea Bio Funding Round
On 3/27/2025, Galatea Bio raised $25 million in financing from Alexandria Venture Investments, AME Cloud Ventures and CEI Community Ventures.
Transaction Overview
Company Name
Announced On
3/27/2025
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand its clinico-genomics platform to integrate multi-modal data and AI-driven applications to refine genetic risk analysis for Mendelian and complex diseases, biomarker discovery, and clinical trials optimization.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
14350 Commerce Way
Miami Lakes, FL 33016
USA
Miami Lakes, FL 33016
USA
Phone
Website
Email Address
Overview
Galatea Bio is a biotechnology company committed to driving groundbreaking discoveries in healthcare by pairing genetic diversity with cutting-edge data analytics. Our passion is fueled by a focus on populations historically underrepresented in genetics research. We achieve this by leveraging our world-class clinical network and biobank, cutting-edge algorithms, and innovative analyses to discover and validate new tests and treatments that will improve the lives of all.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Carlos Bustamante
Browse more venture capital transactions:
Prev: 3/27/2025: EDGE Boost venture capital transaction
Next: 3/27/2025: Yutori venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs